Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00453336 · ClinicalTrials.gov registry record · Phase 2
Photodynamic Therapy With Porfimer Sodium in Treating Patients With Precancerous Lesions, Cancer, or Other Disease of the Aerodigestive Tract
A Phase 2 study, sponsored by University of Miami.
- Completed
- Registry status
- Phase 2
- Development phase
- 45
- Enrollment target
NCT00453336 is a Phase 2 study that has completed, run by University of Miami. The registered enrollment target is 45 participants.
The verdict
NCT00453336, a Phase 2 study, has completed, sponsored by University of Miami.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 45 participants
- Enrollment target
Study Summary
RATIONALE: Photodynamic therapy uses a drug that becomes active when it is exposed to a certain kind of light. When the drug is active, precancerous cells and cancer cells are killed. PURPOSE: This phase II trial is studying the side effects and how well photodynamic therapy with porfimer sodium works in treating patients with precancerous lesions, cancer, or other disease of the aerodigestive tract.
Interventions
- PROCEDURE Photodynamic Therapy
- DRUG Porfimer Sodium
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2003-06 |
| Est. Completion | 2010-05 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00453336
The ClinicalTrials.gov registry entry for NCT00453336 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Photodynamic Therapy is the first listed.
NCT00453336 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00453336 about?
NCT00453336 is a clinical study titled "Photodynamic Therapy With Porfimer Sodium in Treating Patients With Precancerous Lesions, Cancer, or Other Disease of the Aerodigestive Tract". RATIONALE: Photodynamic therapy uses a drug that becomes active when it is exposed to a certain kind of light. When the drug is active, precancerous cells and cancer cells are killed. PURPOSE: This phase II trial is studying the side effects and how well photodynamic therapy with porfimer sodium wo...
What is the current status of trial NCT00453336?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 45 participants. The study started on 2003-06. Estimated completion is 2010-05.
What interventions are being tested in trial NCT00453336?
The interventions under investigation include: Photodynamic Therapy (PROCEDURE), Porfimer Sodium (DRUG).
Who is sponsoring clinical trial NCT00453336?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.